STSN Company Profile and Key Details

The stock is currently mid-range between its 52-week high and low $0.00 and $0.02. With a market capitalization of about $1.59 million, Stemsation International, Inc. is classified as a micro-cap and shows market-like volatility (beta ~0.93). Key stats such as the average daily volume over the past year has been around 196.49 thousand shares, volume is running light vs its 52-week average. Headquartered in Plantation, FL, Stemsation International, Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Ray C. Carter Jr., the company employs approximately 4 people and listed since January 31, 2008. StemSation International, Inc., headquartered in Boca Raton, Florida, specializes in the development, manufacture, and distribution of natural wellness products.

Average 10-day trading volume of 15.21 thousand shares is below the 3-month average of 223.34 thousand, indicating normal recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Our AI price prediction model suggests that Stemsation International, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Stemsation International, Inc. trading at a premium to the broader market with a P/E of -11.43.

Stemsation International, Inc. trades at a P/E ratio of -11.43, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.44 suggesting the stock is closer to book value. The P/FCF stands at -4.52, also below market averages.